[av_one_full first min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=”]
[av_heading heading=’Sanofi agrees to refund PH Dengvaxia expense’ tag=’h3′ style=’blockquote modern-quote’ size=” subheading_active=’subheading_below’ subheading_size=’15’ padding=’10’ color=” custom_font=” av-medium-font-size-title=” av-small-font-size-title=” av-mini-font-size-title=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
BY PRINCE GOLEZ
[/av_heading]
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
January 16, 2018
[/av_textblock]
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
MANILA – French pharmaceutical company Sanofi Pasteur agreed to refund the Department of Health (DOH) P1.4 billion for the unused dengue vaccine Dengvaxia.
But Sanofi clarified that its decision to reimburse was “not related to any safety or quality issue with Dengvaxia.”
It only wanted to “work more openly and constructively with the DOH to address the negative tone toward the dengue vaccine in the Philippines today,” Sanofi said in a statement on Monday.
“Sanofi Pasteur strongly believes that this tone is due to a misunderstanding of the benefits and risks associated with the dengue vaccine and a lack of awareness among the general public, particularly parents of vaccinated children, that the overall benefit of dengue vaccination remains positive in high endemic countries like the Philippines,” the company said.
The Health department asked for the refund last week via a letter to Sanofi Pasteur Asia Pacific head Thomas Triomphe.
“The Dengvaxia vaccine which Sanofi Pasteur aggressively promoted and sold to the Philippine government has undeniably failed to deliver its supposed clinical benefit and safety claims, hence, considered defective under Philippine civil laws,” Secretary Francisco Duque wrote./PN
[/av_textblock]
[/av_one_full]
